Key facts
- This page summarizes Thomas Cancro's Form 4 filing for Tabula Rasa HealthCare, Inc..
- 1 reported transaction and 0 derivative rows are listed below.
- Accepted by SEC: 21 Apr 2023, 17:21.
Thomas Cancro - 19 Apr 2023 Form 4 Insider Report for Tabula Rasa HealthCare, Inc.
- Reporting relationship
- CHIEF FINANCIAL OFFICER
- Issuer ticker
- N/A
- Reported as of
- 19 Apr 2023
- Net transaction value
- $0
- SEC form
- 4
- Accepted by SEC
- 21 Apr 2023, 17:21:14 UTC
- Prior SEC filing
- 14 Dec 2022
- Next SEC filing
- 14 Nov 2023
- Source filing
- View source filing
- Reporting owner signature
- Brian W. Adams, by Power of Attorney
Source evidence
Original filing metadata and source links for verification.
5 source fields
Reporting owner
1 detail
Key filing fact
Thomas Cancro filed Form 4 for Tabula Rasa HealthCare, Inc. on 21 Apr 2023.
Change
- Previous filing in this sequence was filed on 14 Dec 2022.
- Current net transaction value: $0.
Research use
- This tells you what this filing adds before you inspect full transaction and derivative tables.
- You can trace every row back to the original SEC filing document.
Evidence
Filed on Form 4
View source filing
Ownership activity is grounded in SEC Form 4 disclosures.
Reported non-derivative transactions
Shares, units, or other non-derivative securities reported in this filing.
TRHC
transaction
Common Stock
Award
- Transaction value
- $0
- Shares
- +37,037
- Change %
- +18%
- Price
- $0.000000
- Shares after
- 248,537
- Date
- 19 Apr 2023
- Ownership
- Direct
- Footnotes
- F1
* marks a reported price that did not pass the local price check.
Additional SEC filing notes
Filing notes and footnotes
Explanation of responses 1 footnote
Footnote F1
Grant of restricted stock units. Each restricted stock unit represents a contingent right to receive one share of the issuer's common stock.